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a b s t r a c t
Background: Cisplatin resistance remains a major clinical obstacle to the successful treatment of non-small cell
lung cancer (NSCLC). Scribble contributes to ROS-induced inﬂammation and cisplatin-elevated toxic reactive oxygen species (ROS) promotes cell death. However, it is unknown whether and how Scribble is involved in the
cisplatin-related cell death and the underlying mechanism of Scribble in response to chemotherapies and in
the process of oxidative stress in NSCLC.
Methods: We used two independent cohorts of NSCLC samples derived from patients treated with platinumcontaining chemotherapy and xenograft modeling in vivo. We analyzed the correlation between Scribble and
Nox2 or Nrf2/PD-L1 both in vivo and in vitro, and explored the role of Scribble in cisplatin-induced ROS and apoptosis.
Findings: Clinical analysis revealed that Scribble expression positively correlated with clinical outcomes and chemotherapeutic sensitivity in NSCLC patients. Scribble protected Nox2 protein from proteasomal degradation.
Scribble knockdown induced cisplatin resistance by blocking Nox2/ROS and apoptosis in LRR domaindependent manner. In addition, low levels of Scribble correlated with high levels of PD-L1 via activation of
Nrf2 transcription in vivo and in vitro.
Interpretations: Our study revealed that polarity protein Scribble increased cisplatin-induced ROS generation and
is beneﬁcial to chemotherapeutic outcomes in NSCLC. Although Scribble deﬁciency tends to lead to cisplatin resistance by Nox2/ROS and Nrf2/PD-L1, it is still possible that Scribble deﬁciency-induced PD-L1 may yield beneﬁts in immunotherapy.
Fund: National Key R&D Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Cisplatin (cis-diamminedichloro-platinum(II), CDDP) is one of the
most commonly used chemotherapeutic agents in the treatment of cancer, in particular, in non-small cell lung cancer (NSCLC) [1,2]. Platinumcontaining drugs are used as ﬁrst-line chemotherapeutic agents for the
treatment of human NSCLC [3]. Unfortunately, current cisplatin-based
treatments for advanced NSCLC result in only modest responses [4,5].
Within the population of patients, the selection of pre-existing resistant
cells and/or acquisition of resistance during treatment with chemotherapy has been proposed. Development of resistance to cisplatin is considered a primary factor in NSCLC relapse [6,7].

https://doi.org/10.1016/j.ebiom.2019.08.057
2352-3964/© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Research in context
Evidence before this study
Cisplatin resistance remains a major clinical obstacle to the successful treatment of non-small cell lung cancer (NSCLC). Chemotherapeutic agents generate reactive oxygen species (ROS) in
patients undergoing chemotherapy. The only enzyme family that
produces ROS as its main product is the NADPH oxidase (Nox)
family. Nuclear factor, erythroid 2 like 2 (Nrf2), as an antioxidant
regulator, promotes expression of PD-L1, which in turn contributes to chemoresistance in solid tumors. Scribble is considered a
tumor suppressor in multiple solid tumors and mostly localizes primarily to the cell membrane, as does Nox2, this subcellular location is critical for the Scribble's function in epithelial cells. Our
preliminary data suggested that Scribble contributes to Noxinduced ROS generation in inflammation. Current studies focus
on the role and underlying mechanism of activity of Scribble in cisplatin resistance of NSCLC.
Added value of this study
Our clinical studies from two independent NSCLC cohorts suggested that Scribble levels were positively associated with clinical
outcomes and chemotherapeutic sensitivity in NSCLC patients
who had received platinum-containing first-line chemotherapy.
Downregulation of Scribble increased proteasomal degradation
of Nox2 to block Nox2-derived ROS signaling and apoptosis in a
LRR domain-dependent fashion, subsequently inducing cisplatinrelated drug resistance in NSCLC. Also, Scribble decreased PDL1 by inhibiting Nrf2 transcription in NSCLC and cisplatinresistant cell lines, which might reflect (in part) a response to the
abnormal Scribble/Nox2/ROS signaling.
Implications of all the available evidence
Our findings demonstrated that loss of Scribble confers cisplatin
resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/
PD-L1 signaling. Chemotherapy is suitable for in first-line treatment in Scribblehigh patients, whereas, PD-1/PD-L1 checkpoint
blockades might be the preferred choice for first-line treatment in
Scribblelow patients.

Scribble (Scrib) is one component of the Scribble/Discs large (Dlg)/
Lethal giant larvae (Lgl) polarity complex, which localizes to the
basolateral side of the epithelial cell membrane [8,9]. Loss of Scribble expression results in cancerous overgrowth of imaginal discs in Drosophila
larvae, suggesting a tumor suppressor role for Scribble [8,10,11]. Human
Scribble (hScrib) is a functional homologue of Drosophila Scribble [12];
mislocated or deregulated hScrib expression contributes to tumorigenesis including proliferation, invasion, metastasis and drug resistance in
various of epithelial cancers [9,13–16]. In particular, Scribble acts
via the MAPK-ERK pathway to decreases the tumor burden in the
KrasLSL-G12D lung cancer mouse model [14]. However, the mechanism underlying the tumor suppressor function of Scribble as wellas its potential
relevance to the efﬁcacy of chemotherapy in NSCLC is poorly understood.
Chemotherapeutic agents generate reactive oxygen species (ROS) in
patients undergoing cancer therapy, in whom toxically oxidative stress
is an important contributor to the response to anticancer therapies
[17–19]. NADPH oxidases (Nox) family has been identiﬁed as one of
the major sources of ROS generationin cancer cells [20,21]. Among
those Nox family members, Nox2 (also referred to as gp91phox), is robustly expressed in lung alveolar epithelial cells and is involved in the
regulation of epithelial cell function, a pattern that is similar to that of
Scribble [20,21]. Furthermore, it has been reported that Scribble is

essential for the interaction with endogenous p22phox and contributes
to Nox complex activation and ROS generation in inﬂammation in primary myeloid cells [22]. However, it is unknown whether and how
Scribble is involved in Nox2/ROS signaling in chemotherapy in NSCLC.
Nuclear factor, erythroid 2 like 2 (Nrf2) is considered an antioxidant
proteins-associated transcription factor [23]. The molecular regulation
of the well-known kelch like ECH associated protein 1 (Keap1)/Nrf2
system acts as a sensor responding to changes in redox homeostasis.
Under homeostatic and stress-free conditions, cellular Nrf2 abundance
is maintained at a very low level because the ubiquitin E3 ligase complex composed of Keap1 and Cullin 3 (Cul3) speciﬁcally promotes the
ubiquitination and proteasomal degradation of Nrf2 [24,25]. In contrast,
the malignant tumors, including NSCLC, exhibit constitutive activation
of Nrf2 [26,27]. Interestingly, previous studies have shown that Nrf2 directly induces PD-L1 expression in melanoma [28]. Notably, conventional chemotherapy-induced PD-L1 expression was demonstrated to
promote chemoresistance in NSCLC [29–32]. Whether Nrf2/PD-L1
might serve as the master signaling to promote cancer and increase
chemoresistance is not yet well known. Furthermore, are there other
speciﬁc mechanisms causing sustainable high levels of Nrf2 activation?
Additionally, with the approval of PD-L1/PD-1 checkpoint-based immunotherapy in lung cancer [33,34], a better understanding of the molecular basis of cisplatin resistance and the effect of cisplatin resistance on
PD-L1/PD-1 checkpoint are warranted in order to elucidate the mechanisms and markers underlying this drug-resistant phenotype and to facilitate the implementation of precision medicine.
Herein, we discovered that loss of Scribble conferred cisplatin
resistance in NSCLC. Scribble interacted with Nox2 in a LRR domaindependent manner in the human bronchial epithelium cell line
BEAS-2B. Mechanistically, Scribble stabilized Nox2 protein via inhibiting
proteasomal degradation, thereby promoting ROS production and leading to cisplatin-induced apoptosis in NSCLC; additionally, Scribble levels
negatively correlated with PD-L1 and Nrf2 levels in vivo and in vitro, a
correlation that might be partially regulated by ROS in NSCLC. Together,
these results suggested that Scribble might be a potential marker that
can be used in chemotherapy as well as in PD-L1/PD-1-based
immunotherapy.
2. Materials and methods
2.1. Tumor samples and patients
This study was approved by the Institute Research Ethics Committees of Zhongshan Hospital, Fudan University. Two validated cohorts
of patients with NSCLC were enrolled in this study, in which patients
must have been pathologically conﬁrmed with NSCLC. The ﬁrst cohort
consisted of 115 patients who had not previously received chemotherapy. Tumor specimens from these patients were obtained at the time
of surgical resection before chemotherapy. Standard cisplatin or
carboplatin-based ﬁrst-line chemotherapy was used for the treatment
of these 115 NSCLC patients. Several types of outcome measurements
were assessed in this cohort: overall response rate (ORR) (the sum of
complete response [CR] and partial response [PR]), progression-free
survival (PFS), and overall survival (OS). The second cohort consisted
of 72 NSCLC patients from Zhongshan Hospital (Fudan University).
Paired samples, embedded by formalin-ﬁxed parafﬁn, were obtained
from these patients who underwent operations and matched all clinicopathologic variables, with a median follow-up time of 10 years. For the
two cohorts, tumor tissues were stained for Scribble protein using
immuohistochemical (IHC) staining (see below).
2.2. Evaluation of clinical response
The chemotherapeutic response of the tumors were clinically evaluated according to the WHO criteria as follows: (1) CR, disappearance of
all known disease; (2) PR, 50% or more decrease in the entire tumor
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burden; (3) stable disease (SD), b50% decrease or b25% increase in the
entire tumor burden; and (4) progressive disease (PD), 25% or greater
increase in the entire tumor burden or appearance of new lesions. For
our analysis, subjects with CR and PR were deﬁned as responders
(sensitivityhigh); SD or PD were deﬁned as non-responders
(sensitivitylow).
2.3. IHC
IHC staining for Scribble was performed as described previously [35].
Resulting images were concurrently evaluated by two independent pathologists in the Department of Pathology, Zhongshan Hospital (Fudan
University). Staining intensity was scored using a four-category grading
system: I, no staining; II, weak staining; III, moderate staining; and IV,
strong staining [36]. For classiﬁcation of Scribble protein staining in
this study, samples with moderate or strong staining (Grade III or IV)
were deﬁned as Scribblehigh; samples with no or weak staining (Grade
I or II) were deﬁned as Scribblelow.
2.4. Cell lines and reagents
The following cell culture lines were obtained as stocks from our laboratory collection: lung cancer cell lines CRL-5803, CRL-1848, A549, HTB177, HTB-182, HCC827, CRL-5883, CRL-5866; stomach cancer cell lines
MGC803 and AGS; human cervical carcinoma line HeLa and human endometrial carcinoma line HEC-1-A. CRL-1848/CDDP, MGC803/5-FU, and
AGS/5-FU were CDDP- or 5-FU (5-ﬂuorouracil)-resistant isolates selected
in our laboratory from the respective parent using standard methods
[37,38]. Normal human bronchial epithelium cell line BEAS-2B and
NSCLC cell line CRL-5800 were kindly provided by Dr. Guohong Hu.
Lines SKOV-3 and SKOV-3/CDDP were purchased from Shanghai
Xuanyan Biotechnology Company. Lines SGC7901, and SGC7901/CDDP,
MCF-7, and MCF-7/Adr were purchased from Shanghai Bogoo Biotechnology Company. Cisplatin, 5-FU, N-acetyl-L-cysteine (NAC), dipenylene
iodonium chloride (DPI), cycloheximide (CHX), gp91ds-tat, apocynin,
and MG132 were purchased from Sigma-Aldrich (St. Louis, MO, USA).
FuGENE 6 was purchased from Roche (Roche, Inc., USA). Other plasmids,
RNAi vectors, Scrib (WT) and Scrib (Mut) constructs, and corresponding
sequences have been described previously [16].
2.5. Cell viability assays
Cells (3000/well) were seeded in 96-well plates in triplicate. Cells,
seeded for 24 h, were exposed to different concentrations of drugs for
another 48 h. Then MTT solution (5 mg/ml, 20 μl/well, Sigma) was
added to the plate and cells were incubated for 4 h at 37 °C. The supernatant was discarded; DMSO (100 μl/well) was added to the plates and
crystals were allowed to dissolve for 30 min at 37 °C. Absorbance at a
wavelength of 570 nm was measured with a microplate reader (BioRad, CA, USA). Results were expressed as the percentage of viable cells
in drug-treated wells vs medium-treated control wells and were plotted
as a drug dose-dependent cell survival curve.
2.6. Cell apoptosis assays
Cells (1 × 10 [6]/well) were seeded in 6-well dishes and treated with
cisplatin for 24 h or 48 h prior to analysis. Flow cytometric analysis was
performed as described previously [15].
2.7. ROS assays
Intracellular ROS levels were measured using the ﬂuorescent dye
2′,7′- dichloro-ﬂuorescein diacetate (DCFH-DA) (Invitrogen). Cells
were plated in 6-well culture plates, incubated overnight, and treated
with cisplatin for 24 h. Flow cytometric analyses (10,000 events per
sample) were performed in a FACS Aria™ ﬂow cytometer (Becton
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Dickinson, USA) with extinction and emission at 485 and 538 nm, respectively, and data then were evaluated with ﬂowJo13.1 software.
2.8. Western blot
Drug-induced apoptosis was evaluated 24 h after drug treatment.
Western blot analysis was performed as described previously [35]. Antibodies against PARP, caspase-3, E-cadherin, Nrf2, HSP90, β-actin,
ERCC1, ATM, CHK1, TOPOII, CTR1, ATP7B, GAPDH, Flag-tag, and HA-tag
were obtained from Cell Signaling Technology (Boston, MA, USA);
anti-Scribble antibody (C-20) was obtained from Santa Cruz Biotechnology (CA, USA); anti-Nox2/gp91phox antibody was obtained from
Abcam (Cambridge, UK); anti-PD-L1 antibody was obtained from
eBioscience.
2.9. Co-immunoprecipitation (Co-IP)
Cells (3 × 106 /sample) were collected and lysed in a modiﬁed IP
buffer (containing protease inhibitor cocktail). Proteins were co-IPed
with anti-Scribble or anti-Flag antibody, and western blot analyses of
electrophoresed proteins were performed using the indicated
antibodies.
For cell membrane-related IP assay, the cell membrane was extracted using ProteoExtract Native Membrane Protein Extraction Kit
(Millipore) according to the manufacturer's protocol and the cell membrane protein lysate then was used to perform the IP assay.
2.10. Immunoﬂuorescence (IF) imaging
The IF assay was performed as described previously [35].
Anti-Scribble antibody (C-20): Santa Cruz Biotechnology (CA, USA);
anti-Nox2/gp91phox antibody: Abcam (Cambridge, UK); and anti-PDL1 antibody: eBioscience.
2.11. Animal experiments
All animal experiments were performed in accordance with a protocol approved by the Institutional Animal Care and Use Committee
(IACUC) of the Institute for Shanghai Institute of Nutrition and Health,
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All animal experiments were approved by the IACUC of the Institute for Shanghai Institute of Nutrition and Health, Shanghai Institutes
for Biological Sciences, Chinese Academy of Sciences (Shanghia, China).
To generate Scribble conditional-knockout mice, Scribbleﬂox/ﬂox mice
were crossed with KrasG12D mice, yielding Scribbleﬂox/ﬂoxKrasG12D mice.
To knockout Scribble and activate KrasLSL-G12D in the lung, 8-week-old
Scribbleﬂox/ﬂoxKrasG12D mice were anesthetized and infected with the
Adcre virus (2 × 10^ [6] pfu/mouse in 62.5 μl DMEM containing
5.8 mM CaCl2) via intranasal instillation. The resulting Scribbleﬂox/ﬂox
KrasLSL-G12D mice were sacriﬁced at 12 weeks post-virus infection, and
lung tissues were collected for further analysis.
For xnograft experiments, nude mice (4 to 6 weeks old) were used
for tumor cell implantation. Tumor cells (1 × 106 /mouse) in 25 μl
serum-free medium (mixed with Matrigel at a 1:1 ratio) were injected
into the left inguinal region using a 100-μl syringe. Tumor growth was
monitored every other day. Tumor mass (weight in g) was determined
by the formula for the volume of an ellipsoid sphere (V = ½(a × b [2]),
where “a” is the long dimension and “b” is the perpendicular short dimension, in cm) and assuming a density of unity. When tumors
achieved the desired size (about one week after tumor cell implantation), mice harboring palpable tumors were weighed and randomly
sorted into control and treatment groups. Cisplatin was dissolved in
physiological saline and administered (via i.p. injection; every other
day for 15 days) at a doses of 2·5 mg/kg. The control group received
equivalent volumes of saline only. The body weight was recorded one
day after the ﬁnal cisplatin dose.
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2.12. Statistical analyses
All numerical data are presented as the mean ± S.D. The data were
analyzed using a two-tailed non-paired Student's t-test with homoscedasticity assumed. Comparisons of patient and tumor characteristics
were constructed using the χ2 test. Survival curves were constructed
using the Kaplan–Meier method. All statistical analyses were performed
using Prism (version 5.0; GraphPad, San Diego, CA, USA) software. P
values of b0.05 were considered statistically signiﬁcant.
3. Results
3.1. Low levels of Scribble are associated with poor survival and worse chemotherapeutic outcomes in human NSCLC
To determine the potential of Scribble as an effective clinical biomarker to predict the prognosis of chemotherapy, Scribble level was
correlated to clinical outcomes in NSCLC patients who had received

platinum-based chemotherapy after diagnosis. IHC staining was revealed that Scribble level was strongly positively related to
progression-free survival (PFS) and overall survival (OS) in this cohort
(n = 115; see Supplementary Table S1 for patients characteristics)
(Fig. 1a–c and Table 1; PFS, P = 0·012; OS, P = 0·009; Kaplan-Meier
analysis). Further analysis of patients' responses to the ﬁrst-line
platinum-containing chemotherapy showed lower sensitivity in 58
out of 68 Scribblelow patients (85·29%), which suggested that Scribble
levels were positively correlated with chemotherapeutic sensitivity in
NSCLC (Fig. 1d and Table 1). Consequently, it is reasonable to consider
the potential of Scribble level in predicting chemotherapeutic sensitivity. Additionally, multivariate Cox regression analyses demonstrated
that Scribble provided prognostic information independent of all standard clinicopathologic variables tested, including TNM stages, sex, age,
pathology, EGFR-TKI status and performance status across survival
types (Supplementary Table S2). To further identify the efﬁciency of
Scribble for predicting the chemotherapeautic outcomes, another independent platinum-based chemotherapy NSCLC cohort (n = 72) was

Fig. 1. Low levels of Scribble are associated with poor survival and worse chemotherapeutic outcomes in human NSCLC. (a) Immunohistochemical (IHC) staining for Scribble in 115 NSCLC
specimens (scale bars: 50 μm (upper row) or 100 μm (lower row)). (b–c) Kaplan-Meier analysis of progression-free survival (PFS) (b) and overall survival (OS) (c) of 115 cases with
NSCLC. Patients with NSCLC were classiﬁed based on IHC-determined Scribble protein levels (high-level expression (Scrib-H) = Grade III or IV; low-level expression (Scrib-L) = Grade
I or II) (Kaplan-Meier analysis). (d) IHC staining for Scribblein NSCLC specimens from patients of the ﬁrst cohort that had different responses to chemotherapy (sensitivityhigh = CR or
PR; sensitivitylow = SD or PD). Scale bars, 50 μm. **P b .01, chi-square test. (e) IHC staining for Scribble in NSCLC specimens before and after chemotherapy respectively. Scale bars, 50 μm.
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Table 1
Relationship between Scribble expression and clinical responses to platinum-containing
chemotherapy.

PFS (months)
Median
95%CI
OS (months)
Median
95%CI
Tumor response
CR
PR
SD
PD
ORR (%)
DCR (%)

Scribble Ha

Scribble L

P value

5.5
4.0–6.9

3.6
2.7–4.5

0.012

19.0
17.1–20.9

9.5
4.9–14.1

0.009

0
18
21
8
38.5
82.3

0
10
40
18
12.3
73.1

0.004
0.234

Abbreviations: Scribble H, Scribble high expression; Scribble L, Scribble low expression.
a
Comparison between two groups with Chi-square test.

evaluated; in this second cohort patients were matched for all clinicopathologic variables and were treated with platinum-containing chemotherapy followed by tumor sampling. Kaplan–Meier analyses of
this second cohort suggested that the Scribble level was signiﬁcantly
prognostic speciﬁcally in platinum-based chemotherapy-treated patients (Supplementary Fig.S1a and Supplementary Table S3).
Furthermore, we obtained 31 paired samples from cisplatin-treated
NSCLC patients undergoing platinum-based chemotherapy; speciﬁcally,
the paired samples were obtained from biopsies performed before and
after treatment. We evaluated these samples to assess the effect of
platinum-containing chemotherapy on Scribble expression. The results
showed that most of the surviving cells exhibited low Scribble expression in approximately 77·4% (24/31) of the patients after chemotherapy
(Fig. 1e). Statistical analysis of the number of decreased metastasis sites
after platinum-containing chemotherapy further suggested that patients' with decreased Scribble levels were less sensitive to chemotherapy (Supplementary Fig.S1b). Collectively, these data demonstrated
that Scribble expression level may be a crucial marker for the development of clinical resistance to highly efﬁcient chemotherapy.
3.2. Scribble is required for efﬁcacious cisplatin-containing treatment of
NSCLC in vivo
Next, to determine the inﬂuence of Scribble on the response to cisplatin treatment under physiological conditions, nude mice were implanted subcutaneously with a control cell line or with the stable KD
human lung cancer cell line CRL-5803 (Scribble RNAi), and tumors
were allowed to develop. The KD cell line constitutively expresses a
short hairpin targeting the Scribble transcript to reduce Scribble expression; the control line expresses an RNAi that does not target this gene
[16]. The expressions of Scribble of before and after xenografts were determined by western blot to conﬁrm the knockdown efﬁciency of Scribble in CRL-5803 (Supplementary Fig.S2a). When the xenografts reached
palpable volumes, mice were treated by intraperitoneal injection (every
other day for two weeks) with saline (vehicle) or cisplatin (2·5 mg/kg).
After 15 days, animals were euthanzied, and tumors were recovered
and weighed. For both control cells and Scribble KD cells, cisplatin injection attenuated tumor growth compared to the saline treatment (P b
0·05 for each cell line, student's t-test). However, among the cisplatintreated animals, residual tumors in Scribble KD-implanted mice
remained signiﬁcantly larger than those in control cell-implanted
mice (P b 0·05, student's t-test) (Fig. 2a–c). In addition, Kaplan–Meier
analysis demonstrated that mice with CRL-5803 Scribble RNAi cells exhibited shorter overall survival time after cisplatin treatment compared
to the control group (Fig. 2d). Equivalent experiments using control and
KD constructs in a cisplatin-sensitive cancer cell line (HEC-1-A) yielded
similar results (Supplementary Fig.S2b–d). Since HEC-1-A is a human

69

endometrial carcinoma cell line, these studies demonstrated that Scribble may mediate the efﬁcacy of cisplatin-based treatment in NSCLC as
well as other (non-NSCLC) epithelial cancers in vivo.
3.3. Scribble sensitizes cisplatin and induces apoptosis via elevating ROS
generation in NSCLC cells
To examine the role of Scribble in response to cisplatin treatment in
lung cancer cells, we ﬁrstly tested Scribble protein levels in various
NSCLC cell lines (Supplementary Fig. S3a). Previous studies showed
that many chemotherapeutic drugs including cisplatin dramatically elevate ROS levels to preferentially kill cancer cells, and Nox is critical to
ROS production [19,39,40]. Therefore, ROS levels were measured in
virous cell lines. We found that stable Scribble knockdown (KD, Scrib
RNAi) attenuated the increase in cisplatin-inducing ROS signaling
(Fig. 3a and Supplementary Fig. S3b). Next, to verify whether Scribblemodulated ROS affects the response to cisplatin in NSCLC, we
investigated cell viability in Scribble KD cells challenged with cisplatin.
Compared to control cells, Scribble downregulation increased cell viability and the IC50 (half-maximum inhibitory concentration) of cisplatin approximately 2-fold (Fig. 3b and Supplementary Fig. S3b–d).
Further examination of the levels of apoptotic proteins showed that
Scribble KD decreased cisplatin-resulted in apoptosis and the accumulation of the cleaved-PARP as that of cleaved-caspase-3 (Fig. 3c–d and
Supplementary Fig. S3e), indicating that Scribble promotes cisplatininduced apoptosis and elevates cisplatin sensitivity in NSCLC cells. We
further introduced full-length Scribble into the CRL-5803 Scribble KD
cell lines to rescue the Scribble level. Ectopic expression of Scribble potentiated the accumulation of cleaved-PARP, restored the inhibition of
cisplatin in viability and counteracted the decrease in cisplatininduced apoptosis observed in the KD cell lines lacking such ectopic expression (Fig. 3e and Supplementary Fig. S3f).
Given the excess ROS production is known to trigger apoptosis [41],
we further explored whether Scribble-promoted apoptosis is dependent on ROS generation. Our data suggested that exposure to a ROS
scavenger (NAC) similarly attenuated cisplatin-induced apoptotic signaling in Scribble KD cells (Fig. 3f). Generally, cisplatin resistance is related to the multi-drug resistance (MDR) pathway [40]. Therefore, we
assessed the effect of Scribble on the proteins' expressions involved in
MDR in Scribble KD lung cancer cells, including drug transportation
(CTR1, ATP7B), DNA repair (ATM, ERCC1, CHK1, TOPOII) and aborted
apoptosis (p53 and Bcl2) [7]. The results showed that Scribble deﬁciency has no signiﬁcant effect on the classic MDR pathway in NSCLC
cell lines during the anti-cancer treatment of cisplatin (Supplementary
Fig. S3g).
Collectively, these results demonstrated that knockdown of Scribble
attenuated the response to cisplatin, an effect that was mediated by attenuation of ROS production in NSCLC cells.
3.4. Scribble augments response to cisplatin through NADPH oxidase
pathways
To identify the underlying molecular mechanism of Scribblemediated cisplatin resistance, a DYKDDDDK (Flag)-tag afﬁnity procedure was used to purify a Scribble-containing complex from BEAS-2B
cell line; the components of the resulting complex then were identiﬁed
by mass spectrometric (MS) assay. Interestingly, peptide sequences for
Nox2, a member of the NADPH oxidase family, were extracted, suggesting that Nox2 was involved in Scribble-containing complex (Supplementary Fig. S4a). To identify the potential interacting partners of
Scribble, we performed co-IP and IF assays. The results conﬁrmed that
Scribble interacted with Nox2 in BEAS-2B cell line and demonstrated
that Scribble mainly colocalized with Nox2 on the cell membrane
(Fig. 4a–b and Supplementary Fig. S4b). These observations suggested
that Nox2 may contribute to Scribble regulated ROS signaling and cisplatin sensitivity in NSCLC. Therefore, we extended this analysis by
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Fig. 2. Scribble is required for efﬁcacious cisplatin-containing treatment of NSCLC in vivo. (a–c) Nude mice harboring subcutaneous tumors derived from implanted Control CRL-5803 or
CRL-5803 Scribble KD cells were treated by intraperitoneal injection (on alternate days for two weeks) with vehicle (saline) or 2.5 mg/kg cisplatin. Tumor dimensions were recorded on
every other day and calculated tumor volumes are presented as the mean ± SD for each group (n = 6). Weight of terminal tumors was recorded on Day 15. (d) Kaplan-Meier analysis of OS
of xenograft mice with or without cisplatin treatment. MS: Median Survival (Day). All assays were performed in triplicate and the results are presented as the mean ± S.D. in all panels (b,
c). *P b .05, **P b .01 (Student's t-test).

investigating the effect of Nox2 KD on Scribble-related apoptosis. We
found that small interfering RNA (siRNA)-mediated knockdown of
Nox2 protected cells from cisplatin-induced apoptosis in CRL-1848
with ectopic Scribble expression (Fig. 4c and Supplementary Fig. S4c).
Additionally, the Nox inhibitor DPI and the Nox2-speciﬁc inhibitors,
gp91ds-tat [42], apocynin [43], also were used and the data conﬁrmed
that NADPH oxidase pathways pontentiated on Scribble-induced cisplatin sensitivity (Fig. 4dand Supplementary Fig. S4d–e).
Besides the mechanism of NADPH oxidase-mediated ROS genration,
mitochondrial ROS accumulation has been reported in cisplatin-treated
cells [21]. To exclude a role for mitochondrial ROS, we investigated
whether Scribble affects SOD1-inhibited ROS generation and apoptosis.
The results showed that Scribble elevated ROS generation and apoptosis
in cells with ectopic expression of SOD1, yielding a level of ROS similar
to that observed in the control group (lacking ectopic expression of
SOD1) (Supplementary Fig. S5a–b). Notably, this effect was blocked by
the loss of Nox2 (Supplementary Fig. S5c–d). Thus, our data suggested
that the Scribble-Nox2-ROS axis was independent of SOD1-related mitochondria ROS. Together, these studies provided evidence that Scribble
acts upstream of Nox2-ROS pathway in cisplatin-related apoptosis and
indicated that concomitant loss of Scribble and Nox2 is associated
with chemotherapy resistance.
3.5. Scribble protects Nox2 proteins from proteasomal degradation
To further characterize the association between Nox2 and Scribble in
chemoresistance, we examined the protein levels of Scribble and Nox2
proteins in 6 chemotherapy-resistant cancer cell lines (CRL-1848/
CDDP, SGC7901/CDDP, SKOV-3/CDDP, MCF-7/Adr, MGC803/5-FU, and

AGS/5-FU), in which the IC50 values of drugs were 2- to 20-fold higher
than those in the respective parental lines (data not shown). Notably,
the protein levels of both Scribble and Nox2 were decreased in the
drug-resistant cell lines (compared to the respective parent lines)
(Fig. 5a). Interestingly, IF assays showed that Scribble protein levels
were positively correlated with Nox2 protein levels in NSCLC tumor
samples; additionally, we observed that Scribble colocalized with
Nox2 on the plasma membrane in NSCLC tumor samples (Fig. 5b). To
further assess whether Scribble regulates Nox2 accumulation, Nox2
levels were tested in cells exposed to CHX, an inhibitor of translation.
The data revealed that Nox2 protein had a shorter half-time in Scribble
KD lung cancer cells than in control cells (Fig. 5c), suggesting that Scribble stabilized Nox2 protein. We hypothesized that the effect of Scribble
KD on Nox2 protein accumulation was mediated by proteasomal degradation, an idea that we tested by treating Scribble KD cells with MG132,
a proteasome inhibitor. We found that while Nox2 protein levels were
lower in Scribble KD cells than in control cells. MG132 treatment significantly reversed the loss of Scribble-induced decrease in Nox2 levels
(Fig. 5d). These data suggested that decreased Scribble level (in the
KD cells) left Nox2 more susceptible to proteolytic degradation.
Previous reports indicated that hScrib regulates exocytosis or cell
death by directly binding to βPIX/GIT1, which can recruit Rac1 to form
a functional complex [16,44,45]. Recent studies have shown that Rac
participates in the activation of Nox1 and Nox2: endogenous Rac production is sufﬁcient for Nox1 activation, whereas ectopic expression of
active Rac is required for Nox2 activation [46-49]. We also observed
that Scribble KD abrogated Rac activation in cisplatin-treated cancer
cells (Supplementary Fig. S6). Therefore, Rac1 may mediate Scribbleactivated Nox2/ROS signaling.
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Fig. 3. Scribble sensitizes cisplatin and induces apoptosis via elevating ROS generation in NSCLC cells. (a) Cells (CRL-1848 background) harboring control or Scrib RNAi were treated with
cisplatin (2 μg/ml, 48 h), and the intracellular level of ROS was measured by DCFH-DA ﬂuorescence using ﬂow cytometry. (b) MTT assay was used to assess the relative survival of cells
harboring the control RNAi or Scrib RNAi after treatment with cisplatin at the indicated concentrations. (c) Apoptosis was measured by monitoring annexin V-FITC and PI-double positive
populations. Cells for the assay were plated into a 6-well plate and incubated with or without cisplatin (2 μg/ml) for 36 h, then subjected to ﬂow cytometric analysis. (d) Cells harboring
control or Scrib RNAi were exposed to cisplatin (2 μg/ml, 36 h) and analyzed by western blot analysis with anti-PARP antibody, and then the intensities of protein bands were quantiﬁed.
(e) Ectopic expression of Scrib in CRL-5803 cells harboring the Scrib RNAi plasmid. (f) Cells (CRL-5803 background) harboring control RNAi or Scrib RNAi were pretreated with NAC
(10 mM) for 30 min, then incubated with cisplatin (2 μg/ml, 48 h). Apoptosis was monitored by ﬂow cytometry and (separately) analyzed by western blot analysis with anti-PARP
antibody, and then the intensities of protein bands were quantiﬁed. All assays were performed in triplicate and the results are presented as the mean ± S.D. in all panels (a–f). *P b
.05, **P b .01, ***P b .001 (Student's t-test).
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Fig. 4. Scribble augments response to cisplatin through NADPH oxidase pathways. (a) IP assay showing the interaction between endogenous Scribble and Nox2 in BEAS-2B. (b) Cell
membrane proteins were extracted for an IP assay in which the Scribble is shown to speciﬁcally bind to Nox2 localized to the cell membrane. E-cadherin, a positive cell membrane
protein, was included as a positive control for fractionation. T, total lysate; M, cell membrane lysate; non-M, lysate without cell membrane. (c) Cells (CRL-1848 background) harboring
control or Scrib-WT contructs were transformed with Nox2 siRNA for 24 h, then treated with cisplatin (2 μg/ml, 48 h). Apoptosis and cleaved-PARP level in the treated cells were
monitored by ﬂow cytometry and western blot, respectively. (d) Cells (CRL-1848 background) harboring control or Scribble overexpression contructs were pretreated with gp91 dstat (1 μM), a Nox-speciﬁc inhibitor, for 30 min, then incubated with cisplatin (2 μg/ml, 48 h). Apoptosis and cleaved-PARP levelweremonitored by ﬂow cytometry and western blot,
respectively. All assays were performed in triplicate and the results are presented as the mean ± S.D. in panels (c, d). *P b .05, **P b .01 (Student's t-test).

3.6. Scribble binds to Nox2 in a LRR domain-dependent manner to induce
ROS generation and apoptosis
Next, to explore the mechanism by which Scribble interacts with
Nox2, we performed in vitro pull-down assays using individual HAtagged Scribble subdomains (designated here as A: LRR domain, B:
LAPSD domain, C: the ﬁrst two PDZ domains, or D: the last two PDZ domains) [50] in combination with a Flag-tagged Nox2 C-terminal domain
(Flag-Nox2). Among the four Scribble subdomains, the LRR domain exhibited strong binding to the Nox2 C-terminus (Fig. 6a), suggesting that
the interaction between Scribble and Nox2 occurrs via these respective
subdomains.
To directly investigate whether Scribble function in cisplatin sensitivity can be antagonized through blocking its binding to Nox2, we
employed overexpression constructs that encode wild-type or mutant
Scribble proteins, respectively. Speciﬁcally, the mutated Scribble

encodes a protein in which a conserved Proin in LRR domain is replaced
with a Leu residue (P305L, Mut); this substitution has been shown to
disrupt membrane binding of LRR domain-containing proteins [9,45].
We further evaluated these cell lines using the IP assay. As expected,
the physical interaction between Scribble and Nox2 was abolished by
the P305L substitution (Fig. 6b). The plasmids encoding the WT and
MutScribble were tested in NSCLC cell lines HTB-177 and HTB-182,
which are known to exhibit low expression of the endogenous Scribble.
Notably, the introduction of the plasmid encoding Scribble (WT) sensitized the cells to cisplatin, whereas the plasmid encoding Scribble
(Mut) did not yield a similar effect (Fig. 6c–d and Supplementary
Fig. S7). We also analyzed ROS generation in these cells following cisplatin exposure. The data revealed a rightward shift in the ﬂuorescence
signal (i.e., increased ROS levels) in cells harboring Scribble (WT) but not
in cells harboring Scribble (Mut) (Fig. 6e). Taken together, these results
suggested that Scribble binding to Nox2 via the LRR domain may be
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Fig. 5. Scribble protects Nox2 proteins from proteasomal degradation. (a) Protein levels of Scribble and Nox2 in the indicated chemotherapy-resistant cell lines (and respective parent
lines) were detected by western blot with anti-Scribble and anti-Nox2 antibodies, respectively. HSP90 served as a loading control. (b) The location and intensity of Scribble and Nox2
in NSCLC tissues were detected by IF assay of Scribble (red), Nox2 (green) and DAPI (blue). Scale bars, 50 μm. (c) Cells (CRL-1848 background) harboring control RNAi or Scrib RNAi
were incubated with the protein synthesis inhibitor cycloheximide (CHX, 100 μg/ml); lysed after 0, 6, 9, 12, or 24 h; and Scrib and Nox2 then were detected by western blot. HSP90
served as the loading control. The right plot represents the statistical results of protein intensity. (d) Cells (CRL-1848 background) harboring control or Scrib RNAi were pre-treated
with the proteasome inhibitor MG132 (10 μM, 4 h); Nox2 protein was detected by western blot assay. All assays were performed in triplicate and the results are presented as the
mean ± S.D. in panels (a, c) (Student's t-test).

essential for cisplatin-induced apoptosis and NADPH oxidase-related
ROS generation.
3.7. Loss of Scribble is responsible for elevated PD-L1 expression in NSCLC
Prior studies suggested that PD-L1 expression is increased in
cisplatin-resistant lung cancer cells compared to parent cells, which
led us to explore whether Scribble levels correlate with PD-L1 expression in cisplatin-treated NSCLC cells lines [30–32]. Results from HTB182 cells showed that Scribble overexpression resulted in decreased
PD-L1 expression in HTB-182 cells challenged with cisplatin (Fig. 7a).
In addition, PD-L1 expression was signiﬁcantly increased in these
chemotherapy-resistant cancer cell lines compared to parental cell
lines, revealing that PD-L1 negatively correlated with Scribble expression (Fig. 7b). To further characterize the negative correlation in vivo,
we generated a genetically engineered lung cancer mouse model, in
which KrasLSL-G12DScribﬂox/ﬂox mice were infected with a lentivirus
encoding the Crerecombinase, resulting in lung-speciﬁc deletetion of
the Scrib gene. IF assay then was performed to compare PD-L1 expression levels in lung cancer samples derived from KrasLSL-G12DScrib−/−
mice and KrasLSL-G12DScribﬂox/ﬂox mice (Fig. 7c). We further conﬁrmed
the negative correlation using clinic data from GEO datasets (Fig. 7d).
These analyses indicated that PD-L1 levels were negatively related to
Scribble levels in NSCLC (Fig. 7c–d). Generally, cancer cells exhibit
higher endogenous oxidative stress than normal cells. Consistent with
this observation, we demonstrated that oxidative stress were reduced

in lung cancer tissues from KrasLSL-G12DScrib−/− mice compared to
those from KrasLSL-G12DScribﬂox/ﬂox mice (Supplementary Fig. S8a).
Under homeostatic conditions, feedback regulation on Nrf2 levels
upon excess ROS generation protects cells from oxidative damage.
Under homeostatic and stress-free conditions, cellular Nrf2 abundance
is maintained at a very low level because the ubiquitin E3 ligase complex (composed of Keap1 and Cul3) speciﬁcally promotes the
ubiquitination and proteasomal degradation of Nrf2 [24,25]. Recently,
Nrf2 has been reported to upregulate PD-L1 in melanoma [28] and to
promote chemoresistance in diverse cancers, including NSCLC [30–32].
Thus, these studies led us to hypothesize that Scribble-induced Nox2/
ROS signaling might affect Nrf2/PD-L1 signaling in NSCLC. Therefore,
we empoloyed NAC to attenuate ROS generation in NSCLC HTB-182
cells exposed to cisplatin. The resulting data showed that interference
with ROS generation markedly reversed the Scribble-associated suppression of PD-L1 expression in NSCLC cells (Supplementary Fig. S8b).
Notably, Scribble prevented the accumulation of Nrf2 mRNA in a dosedependent fashion, while ectopic expression of Nrf2 dramatically reversed the Scribble-associated suppression of PD-L1 expression in
HTB-182 cells treated with cisplatin (Supplementary Fig. S8c–d). In addition, both in a mouse model and in clinical samples, Scribble levels
negatively correlated with Nrf2 expression in NSCLC (Fig. 7c and Supplementary Fig. S8e–f). Taken together, our results indicated that Scribble may play a critical role in down-regulation of Nrf2/PD-L1 signaling
in NSCLC, which might also contribute to loss of Scribble-mediated
chemoresistance.
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Fig. 6. Scribble binds to Nox2 in a LRR domain-dependent manner to induce ROS generation and apoptosis. (a) Schematic showing the full-length Scrib protein with Leucine Rich Repeats
(LRR), LAPSD, and PDZ domains, the four separate HA-tagged Scribble subdomains (A: LRR, B: LAPSD, C: ﬁrst two PDZ domains, D: last two PDZ domains) and the Flag-tagged Nox2 Cterminal domain (Flag-Nox2). HA- and Flag-tagged proteins were incubated together; IP was performed using anti-Flag antibody, and resulting precipitates were immunoblotted with
anti-HA antibodies. (b) Cells harboring Control, Scrib (WT), and Scrib (P305L) (Mut) contructs were transformed with the Nox2-Flag-encoding plasmid; lysates were IPed with
anti-Scrib or anti-FLAG antibody, and resulting precipitates were immunoblotted with anti-Scrib or anti-Flag antibody. (c) HTB-177 cells were transformed with constructs encoding
full-length wild-type Scrib protein (Scrib (WT)) or mutant (P305L) Scrib protein (Scrib (Mut)). Apoptosis was monitored by ﬂow cytometry and western blot, respectively. (d) Cells
(HTB-177 background) harboring Control, Scrib (WT), and Scrib (Mut) were treated with cisplatin (2 μg/ml, 48 h), and intracellular levels of ROS were measured using DCFH-DA
ﬂuorescence and ﬂow cytometry. All assays were performed in triplicate and the results are presented as the mean ± S.D. in panels (c, d), *P b .05, **P b .01, ***P b .001 (Student's t-test).

4. Discussion
In this study, we demonstrated that Scribble is critical to the efﬁcacy
of cisplatin-based chemotherapy, an effect mediated by LRR domaindependent protection of Nox2 from degradation, thereby promoting
Nox2/Ros signaling. Interestingly, Scribble is responsible for elevated
Nrf2/PD-L1 expression, which may separately contribute to cisplatin resistance in NSCLC (Fig. 8). In the present work, clinical analysis revealed
that lower Scribble expression predicted poorer outcomes (shorter OS
and PFS, lower chemotherapeutic sensitivity) following platinumcontaining ﬁrst-line chemotherapy. Additional data from in vitro and
in vivo experiments demonstrated that Scribble downregulation significantly decreased sensitivity to cisplatin in NSCLC. Mechanistically, we
found that Scribble correlated with Nox2 accumulation, an effect mediated by decrease in proteasomal degradation of Nox2 protein; this stabilization was critical to cisplatin-induced ROS generation and
apoptosis, which is closely related to cisplatin sensitivity during chemotherapy. Notably, we showed that Scribble dramatically negatively correlated to Nrf2/PD-L1 expression in NSCLC, and that PD-L1 was
expressed at higher levels in chemotherapy-resistant cancer cell lines.

Thus, our study suggested a novel mechanism whereby the polarity
gene Scribble inﬂuences on the cisplatin sensitivity of NSCLC cells.
Accumulating evidence suggests that some chemotherapy drugs induce a high level of oxidative stress [17,51]; platinum coordination
complexes and anthracyclines generate notably toxic ROS [17], which
fosters cell apoptosis via diverse pathways including activation of JNK
and of caspase-8 resulting in cleavage of the downstream mediators
caspase-3 and PARP [21]. In the present study, Scribble boosts
cisplatin-induced apoptosis via enhancing the accumulation of toxic
ROS in NSCLC cell lines (Fig. 3 and Supplementary Fig. S3). Studies
from other labs have suggested that, aside from effects on apoptosis,
toxic ROS also triggers cell cycle arrest [21,52]. However, our prior
work has shown that Scribble has no effect on cell cycle arrest in
NSCLC cells treated with cisplatin [15]. Additionally, in the present
study, the unchangeable MDR pathway indicated that Scribbleinduced ROS is not mediated via DNA damage repair following cisplatin
exposure (Supplementary Fig. S3g). However, recent reports have revealed that Scribble promotes apoptosis in breast cancer cells by ROSdependent ERK and JNK activation [16] and the data in the present
study showed that increased Scribble protein yielded elevated cleavage
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Fig. 7. Loss of Scribble is responsible for elevating PD-L1 expression in NSCLC. (a) Cells harboring control or Scrib OE contructs were treated with or without cisplatin (2 μg/ml, 36 h) and
analyzed by western blotand qPCR. (b) Protein and mRNA levels of PD-L1 in the indicated chemotherapy-resistant cell lines (and respective parent lines) were detected by
immunoblotting and qPCR, respectively. (c) 20-week-old Kras LSL-G12DScribﬂox/ﬂox and Kras LSL-G12DScrib−/− mice were euthanized lung tumor tissues then were harvested and
subjected by IF staining for Scribble and PD-L1. Scale bar, 50 μm. (d) PD-L1 and Scrib mRNA expression in lung tissues from NSCLC patients from GSE19804 data set. All assays were
performed in triplicate and the results are presented as the mean ± S.D. in panels (a, b). *P b .05, **P b .01, ***P b .001 (Student's t-test).

of caspase-3 as well as PARP. Thus, we can not excluded the possibility
that Scribble/Nox2-induced ROS might promote apoptosis by direct effects on caspases function and/or by regulating JNK activation.
ROS can be generated from endogenous sources, including the mitochondrial electron transport chain and oxygen-metabolizing enzymes,

but the only enzyme family that produces ROS as a main product are
the members of Nox family [21]; notably the Nox enzyme, Nox2, exhibits plasma membrane-associated activities in many epithelial cell
types. Coincidentally, Scribble also is localized to the cell membrane
[53]. Our data conﬁrmed that Scribble co-localized with Nox2 on the

Fig. 8. Schematic ﬁgure for the proposed model of regulation of Nox2/ROS and Nrf2/PD-L1 signaling and regulation of cisplatin resistance by Scribble in NSCLC.
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cell membrane (Figs. 4a–b, 5b, and Supplementary Fig. S4a–b). In some
biological contexts, the LRR domain of Scribble is sufﬁcient to provide
Scribble function [54], however, it is relatively few known that the functional patners have been shown to bind to Scribble though the LRR domain. Nonetheless, our work revealed that Scribble interacts with Nox2
via the LRR domain, an interaction that contributes to Scribble/Nox2promoted ROS production and apoptosis in NSCLC cell lines (Fig. 6).
Thus, our ﬁnding expands the number of LRR domain-binding partners
and indicates a function for LRR in cancer. Aside from Nox enzymes, the
mitochondrion is another main source of ROS in cisplatin-treated cells;
in response, the mitochondrial enzyme SOD1 converts superoxide anions to harmless H2O2 and antagonizes potential oxidative damage
in the mitochondrial intra-membrane space [21,55,56]. Our
results (Supplementary Fig. S5a–b) indicated that SOD1-correlated
mitochondrional ROS did not contribute to the Scribble-mediated elevation of ROS and apoptosis.
We and others have reported that hScrib directly binds to βPIX, and
its partner GIT1, which together recruit Rac1 to form a functional complex potentially regulating exocytosis or cell death [16,44,45]. We demonstrated that Scribble KD abrogates Rac activation in cisplatin-treated
cancer cells (Supplementary Fig. S6). Furthermore, previous studies
have shown that Rac participates in activation of the Nox1 and Nox2
[46,47]. However, there might be a difference in the demand for Rac between Nox1 and Nox2; endogenous Rac production is sufﬁcient for
Nox1 activation, whereas ectopic expression of active Rac is required
for Nox2 activation [46-49]. Hence, Scribble-activated Rac1 may be important for the Nox2-ROS pathway. However, it is notable that Scribble
binds to βPIX though PDZ domain [45]; the study from our lab also revealed that ciplatin-resistant NSCLC samples encode Scribble proteins
harboring mutiple mutations in the PDZ domain. Thus, we hypothesized
whether any effects of the PDZ domain on Scribble/Nox2-promoted ROS
and apoptosis are mediated via other proteins binding to PDZ domian, a
concept that will be further explored.
Interestingly, our results showed that Scribble KD was responsible
for proteosome-mediated Nox2 degradation in cancer cells. Others'
work has shown that Scribble recruits PH domain and leucine rich repeat protein phosphatase 1 (PHLPP) to the cell membrane to regulate
Akt activation [57]. Phosphorylation of Akt and GSK3β are required
for E3 ligase β-TrCP-mediated PHLPP degradation [58,59]. Further studies will be needed to determine whether the β-TrCP-mediated
ubiquitination is involved in Scribble-related Nox2 stabilization in
NSCLC cells.
Nrf2 is considered an antioxidant regulator, an effect mediated by
stimulation of the transcription of genes that encoding antioxidant proteins [23]. Under homeostatic and stress-free conditions, ROS levels are
maintained at basal levels by Nrf2 [23,26,27]. Constitutively, activated
Nrf2, as well as and the accumulation of mutagen and abundant ROS
have been observed in cancers including NSCLC [26,27], which hints
that the correlation between Nrf2 and ROS is more complex in a pathological context; the relation between Nrf2 and ROS levels in cancer cells
will need to be further investigated. Cellular Nrf2 abundance is usually
maintained at a very low level by the speciﬁcally promotion of the
ubiquitination and proteasomal degradation of Nrf2 [24,25]. Markedly,
our results indicated that a deﬁciency of Scribble correlated with Nrf2
accumulation both in vitro and in vivo. Recently, other researchers reported that Nrf2 activity yields elevated PD-L1 expression in melanoma
[28], an observation that is consistent with our ﬁndings in HTB-182 cells
exposed to cisplatin (Supplementary Fig. S8d and f). In our study, a negative correlation between Nrf2/PD-L1 and Scribble levels was seen both
in vitro and in vivo (Fig. 7 and Supplementary Fig. S8c–f), demonstrating that Scribble might suppress PD-L1 expression via inhibition of
Nrf2's transcriptional activity. However, depletion of ROS notably restored PD-L1 expression in Scribble overexpression (OE) cell line (Supplementary Fig. S8a–b), suggesting that the effect of Scribble on PD-L1
expression might depend (in part) on ROS level. Previous data have
shown that Scribble (P305L) but not Scribble (WT) activates AKT/

mTOR signaling in breast cancer and that AKT/mTOR is required for
PD-L1 expression in NSCLC [60,61]. Combined with the fact that knockdown of Scribble increases AKT activation [57], we infer that Scribble
(P305L)-activated AKT also might be involved in Scribble-mediated
PD-L1 expression in NSCLC. Data from a number of clinical studies
have suggested that patients with PD-L1high tumor cells experience better outcomes (compared to patients with PD-L1low tumor cells) when
treated with PD-1/PD-L1 checkpoint blockade drugs [34]. In the present
study, Scribblehigh patients exhibited greater sensitivity to cisplatin
therapy than did Scribblelow patients; however, Scribblelow patients
also showed higher PD-L1 expression. Therefore, we concluded that
chemotherapy is a suitable ﬁrst-line treatment for Scribblehigh patients,
whereas, PD-1/PD-L1 checkpoint blockade drugs maybe a preferable
ﬁrst-line treatment for Scribblelow patients.
Altogether, our study revealed that loss of Scribble confers cisplatin
resistance during NSCLC chemotherapy, an effect that is mediated via
Nox2/ROS and Nrf2/PD-L1 signaling. Although Scribble deﬁciency appears to lead to the development of cisplatin resistance (by imapring
Nox2/ROS and Nrf2/PD-L1), it is still possible that Scribble deﬁciencyelevated PD-L1 may offer beneﬁts in immunotherapy.
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